- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Brain metastases: new systemic treatment approaches ; volume:14 ; number:2 ; day:22 ; month:5 ; year:2021 ; pages:198-203 ; date:6.2021
Magazine of European Medical Oncology ; 14, Heft 2 (22.5.2021), 198-203, 6.2021
- Urheber
-
Steindl, Ariane
Bergmeister-Berghoff, Anna Sophie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-021-00709-1
- URN
-
urn:nbn:de:101:1-2021100720524013761144
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Steindl, Ariane
- Bergmeister-Berghoff, Anna Sophie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Publisher Correction: Brain metastases: new systemic treatment approaches
Treatment Options for Brain Metastases
Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series
Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update
Response of treatment-naive brain metastases to stereotactic radiosurgery
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes
Brain metastases from hepatopancreatobiliary malignancies
Current management of brain metastases
Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities
Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients
Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
Publisher Correction: Brain metastases: new systemic treatment approaches
Treatment Options for Brain Metastases
Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series
Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update
Response of treatment-naive brain metastases to stereotactic radiosurgery
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes
Brain metastases from hepatopancreatobiliary malignancies
Current management of brain metastases
Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities
Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients
Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
Publisher Correction: Brain metastases: new systemic treatment approaches
Treatment Options for Brain Metastases
Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series
Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update
Response of treatment-naive brain metastases to stereotactic radiosurgery
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes
Brain metastases from hepatopancreatobiliary malignancies
Current management of brain metastases
Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities
Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients